MyFinsight
Home
Blog
About
Cash and cash
equivalents
$6,962,492
Accounts receivable, net
of allownace of...
$6,621,357
Inventory
$4,711,775
Prepaid expenses and
other assets
$2,485,430
Total property and
equipment
$5,795,848
Intangible assets, net
$21,359,186
Total current assets
$20,781,054
Property and equipment,
net
$4,419,563
Goodwill
$1,532,635
Construction-in-process
$505,307
Right-of-use asset, net
$220,551
Less accumulated
depreciation
$1,376,285
Total assets
$48,818,296
Total liabilities and
stockholders' equity
$48,818,296
Total stockholders'
equity
$27,614,597
Total liabilities
$21,203,699
Accumulated deficit
-$38,965,381
Treasury stock, 18,000
shares at cost
$43,346
Additional paid-in capital
$66,605,483
Total current
liabilities
$21,202,344
Total long-term
liabilities
$1,355
Common stock, 0.001 par
value authorized...
$17,841
Contingent consideration
payable
$10,000,000
Accounts payable and
accrued expenses
$9,457,957
Notes payable
$1,000,000
License fees payable
$434,775
Operating lease
liabilities
$222,471
Other current
liabilities
$75,808
Accrued interest
$11,333
Operating lease
liabilities, less current...
$1,355
Back
Back
Balance Sheet
BioStem Technologies, Inc. (BSEM)
BioStem Technologies, Inc. (BSEM)
source: myfinsight.com